Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
Graham DJ, Izurieta HS, Muthuri SG, Zhang D, Sandhu AT, Lu Y, Zhao Y, Feng Y, Eworuke E, Lyu H, Gandotra C, Smith ER, Avagyan A, Wernecke M, Kelman JA, Forshee RA, MaCurdy TE. Graham DJ, et al. Among authors: avagyan a. J Gen Intern Med. 2021 Dec;36(12):3802-3809. doi: 10.1007/s11606-021-07155-z. Epub 2021 Oct 1. J Gen Intern Med. 2021. PMID: 34599472 Free PMC article.
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.
Norsworthy KJ, Avagyan A, Bird ST, Li Y, Akhtar S, Liao J, Wernecke M, Deisseroth AB, Chuk M, MaCurdy TE, Swain R, Kelman JA, Farrell AT, de Claro RA, Pazdur R, Blumenthal G, Graham DJ. Norsworthy KJ, et al. Among authors: avagyan a. Leukemia. 2020 Nov;34(11):3082-3084. doi: 10.1038/s41375-020-0905-y. Epub 2020 Jun 9. Leukemia. 2020. PMID: 32518418 No abstract available.
Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries.
Graham DJ, Izurieta HS, Zhang D, Avagyan A, Lyu H, Wiederhorn R, Lu Y, Mosholder AD, Smith ER, Zhao Y, Shangguan S, Tsai HT, Pennap D, Sandhu AT, Wernecke M, MaCurdy TE, Kelman JA, Forshee RA. Graham DJ, et al. Among authors: avagyan a. Am J Med. 2023 Oct;136(10):1018-1025.e3. doi: 10.1016/j.amjmed.2023.07.003. Epub 2023 Jul 15. Am J Med. 2023. PMID: 37454868
Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries.
Mosholder AD, Izurieta HS, Zhang R, Shangguan S, Lu Y, Akhtar S, Wernecke M, He J, Chillarige Y, Feng Y, Avagyan A, Leishear K, Forshee RA, MaCurdy TE, Kelman JA, Graham DJ. Mosholder AD, et al. Among authors: avagyan a. Pharmacotherapy. 2024 Oct;44(10):803-810. doi: 10.1002/phar.4614. Epub 2024 Oct 18. Pharmacotherapy. 2024. PMID: 39425479
Publisher Correction: Tumour lysis syndrome.
Howard SC, Avagyan A, Workeneh B, Pui CH. Howard SC, et al. Among authors: avagyan a. Nat Rev Dis Primers. 2024 Sep 9;10(1):65. doi: 10.1038/s41572-024-00557-3. Nat Rev Dis Primers. 2024. PMID: 39251620 No abstract available.
Tumour lysis syndrome.
Howard SC, Avagyan A, Workeneh B, Pui CH. Howard SC, et al. Among authors: avagyan a. Nat Rev Dis Primers. 2024 Aug 22;10(1):58. doi: 10.1038/s41572-024-00542-w. Nat Rev Dis Primers. 2024. PMID: 39174582 Review.
50 results